Trials / Sponsors / IMMUNOe Research Centers
IMMUNOe Research Centers
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Study to Evaluate the Benefit of RUCONEST in Improving Neurological Symptoms in Post COVID-19 Infection Post-Viral Fatigue Syndrome, Post-Viral Disorder (Disorder), Covid19 | Phase 2 | 2021-01-11 |
| Completed | A Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions CVI - Common Variable Immunodeficiency | Phase 4 | 2018-06-13 |
| Unknown | A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrom Pediatric Acute-Onset Neuropsychiatric Syndrome, Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections | Phase 4 | 2017-11-24 |
| Completed | The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 1 Primary Immunodeficiency | — | 2015-06-01 |